[
    {
        "text": "This episode was filmed on July 7, 2020.",
        "start": 0.1,
        "duration": 3.3
    },
    {
        "text": "For our latest COVID-19 coverage, you can\nfind our full playlist in the description.",
        "start": 3.4,
        "duration": 3.58
    },
    {
        "text": "[ ♪INTRO ]",
        "start": 6.98,
        "duration": 3.26
    },
    {
        "text": "Some people who get sick with COVID-19 are\nasymptomatic — meaning they don’t feel",
        "start": 10.249,
        "duration": 3.81
    },
    {
        "text": "any symptoms of the disease.",
        "start": 14.059,
        "duration": 1.691
    },
    {
        "text": "But the infection is still there.",
        "start": 15.75,
        "duration": 1.58
    },
    {
        "text": "In a new study published in Nature Medicine\nlast month, researchers compared what happens",
        "start": 17.33,
        "duration": 4.04
    },
    {
        "text": "in the bodies of people with both symptomatic\nand asymptomatic infections.",
        "start": 21.37,
        "duration": 3.12
    },
    {
        "text": "And it turns out that not having symptoms\nof COVID-19 doesn’t mean your body isn’t",
        "start": 24.49,
        "duration": 5.33
    },
    {
        "text": "affected.",
        "start": 29.82,
        "duration": 1.0
    },
    {
        "text": "There’s a lot we don’t know about asymptomatic\ninfections, including how common they are.",
        "start": 30.82,
        "duration": 3.24
    },
    {
        "text": "We won’t know the real number until all\nthis is over, but some studies have estimated",
        "start": 34.06,
        "duration": 3.65
    },
    {
        "text": "it might be around 35 to 40% of cases.",
        "start": 37.71,
        "duration": 3.02
    },
    {
        "text": "So we really want to know what, if anything,\nhappens to people in these situations.",
        "start": 40.73,
        "duration": 4.03
    },
    {
        "text": "In the new study, researchers in China looked\nat 37 people who tested positive for COVID-19",
        "start": 44.76,
        "duration": 5.6
    },
    {
        "text": "and had mild symptoms, as well as 37 who tested\npositive but didn’t have any symptoms.",
        "start": 50.36,
        "duration": 5.08
    },
    {
        "text": "And even if it wasn’t obvious from the outside\nthat the asymptomatic patients were sick,",
        "start": 55.44,
        "duration": 3.889
    },
    {
        "text": "for most of them you could easily tell by\nlooking at their lungs.",
        "start": 59.329,
        "duration": 2.801
    },
    {
        "text": "Of the 37 patients in that group, 21 had abnormal\nchest CT scans, 11 of them with the ground-glass",
        "start": 62.13,
        "duration": 6.29
    },
    {
        "text": "texture that’s characteristic of COVID-19.",
        "start": 68.42,
        "duration": 2.82
    },
    {
        "text": "Even though they felt fine.",
        "start": 71.24,
        "duration": 1.0
    },
    {
        "text": "The team also confirmed that people who are\nasymptomatic can still be shedding virus particles",
        "start": 72.24,
        "duration": 4.38
    },
    {
        "text": "all over the place — in fact, they tended\nto do it for longer than people who did have symptoms.",
        "start": 76.62,
        "duration": 5.24
    },
    {
        "text": "That’s troubling, because we haven’t ruled\nout the idea that asymptomatic people can spread the disease.",
        "start": 81.86,
        "duration": 4.26
    },
    {
        "text": "And a longer period of viral shedding could\nmean that not only are they contagious, they’re contagious for longer.",
        "start": 86.16,
        "duration": 5.6
    },
    {
        "text": "Or… not.",
        "start": 91.8,
        "duration": 0.999
    },
    {
        "text": "You see, these particles aren’t necessarily\ninfectious.",
        "start": 92.799,
        "duration": 2.871
    },
    {
        "text": "The tests scientists use to detect viral shedding\ndon’t differentiate between broken-down",
        "start": 95.67,
        "duration": 4.25
    },
    {
        "text": "bits of old virus in your snot and fully capable\nviruses that can go on to infect others.",
        "start": 99.92,
        "duration": 4.7
    },
    {
        "text": "So that’s one thing that could definitely\nuse some more research.",
        "start": 104.62,
        "duration": 3.03
    },
    {
        "text": "Because we need to pin down how infectious\nsick people are, whether they’re symptomatic or not.",
        "start": 107.65,
        "duration": 4.37
    },
    {
        "text": "Beyond that, though, the team also looked\nat the immune responses of patients in both groups.",
        "start": 112.12,
        "duration": 4.1
    },
    {
        "text": "Now, we don’t yet know for sure if having\nCOVID-19 makes you immune to getting it again.",
        "start": 116.22,
        "duration": 3.56
    },
    {
        "text": "And even if it does, we don’t know how long\nthat immunity lasts.",
        "start": 119.791,
        "duration": 3.529
    },
    {
        "text": "But what the study found doesn’t exactly\nbuild confidence.",
        "start": 123.32,
        "duration": 2.56
    },
    {
        "text": "They found that three to four weeks after\ntheir initial exposure to the virus, most",
        "start": 125.88,
        "duration": 4.159
    },
    {
        "text": "patients in both groups tested positive for\nantibodies to the virus.",
        "start": 130.039,
        "duration": 3.56
    },
    {
        "text": "The study looked at several types of antibody,\none of which was IgG, the most common kind",
        "start": 133.599,
        "duration": 4.501
    },
    {
        "text": "— though, the symptomatic patients had much\nhigher levels.",
        "start": 138.1,
        "duration": 3.02
    },
    {
        "text": "Then, eight weeks after they were all released\nfrom the hospital, that was still true — those",
        "start": 141.12,
        "duration": 4.28
    },
    {
        "text": "who had been symptomatic had higher levels\nof IgG.",
        "start": 145.4,
        "duration": 2.96
    },
    {
        "text": "But levels had fallen substantially in nearly\nall patients.",
        "start": 148.36,
        "duration": 3.02
    },
    {
        "text": "In 12 of the patients who’d been asymptomatic,\nyou couldn’t detect these antibodies at all anymore.",
        "start": 151.38,
        "duration": 5.0
    },
    {
        "text": "The same was true for only four of the people\nwho’d had symptoms.",
        "start": 156.46,
        "duration": 2.919
    },
    {
        "text": "So, at least among these 74 people, some antibody\nlevels seemed to drop within a few months",
        "start": 159.379,
        "duration": 5.021
    },
    {
        "text": "of being infected, and in those who didn’t\nhave symptoms, they were more likely to drop",
        "start": 164.4,
        "duration": 4.06
    },
    {
        "text": "below what we can detect.",
        "start": 168.46,
        "duration": 1.41
    },
    {
        "text": "That’s not super promising.",
        "start": 169.87,
        "duration": 1.67
    },
    {
        "text": "It’s too early to say, though, that asymptomatic\ncases are at risk of getting infected again.",
        "start": 171.54,
        "duration": 4.9
    },
    {
        "text": "We simply don’t know if re-infection is\na thing yet.",
        "start": 176.44,
        "duration": 2.269
    },
    {
        "text": "And when it comes to immunity, these circulating\nantibodies aren’t the whole story.",
        "start": 178.709,
        "duration": 4.39
    },
    {
        "text": "For example, we might also need to consider\nmemory B cells.",
        "start": 183.099,
        "duration": 2.75
    },
    {
        "text": "Those are the kind of immune cells that produce\nantibodies, and they can produce more in response",
        "start": 185.849,
        "duration": 4.591
    },
    {
        "text": "to a repeat infection of the virus, even if\nthe person didn’t have many antibodies circulating",
        "start": 190.44,
        "duration": 4.3
    },
    {
        "text": "in their blood when they were re-exposed.",
        "start": 194.74,
        "duration": 1.889
    },
    {
        "text": "So even if asymptomatic patients do lose more\nof certain types of antibodies, we don’t",
        "start": 196.629,
        "duration": 4.25
    },
    {
        "text": "yet know what that means for their immunity.",
        "start": 200.879,
        "duration": 2.021
    },
    {
        "text": "The good news is that a new strategy is showing\nup that may help us detect more asymptomatic",
        "start": 202.9,
        "duration": 4.23
    },
    {
        "text": "cases, and it’s cheaper to boot.",
        "start": 207.13,
        "duration": 1.89
    },
    {
        "text": "The workaround is... math.",
        "start": 209.02,
        "duration": 1.389
    },
    {
        "text": "It’s an approach you may have heard referred\nto as pooled or batch testing.",
        "start": 210.409,
        "duration": 4.33
    },
    {
        "text": "Say you have nasal swabs from 60 people you\nneed to test.",
        "start": 214.739,
        "duration": 3.0
    },
    {
        "text": "Two of them are positive, although you don’t\nknow that yet.",
        "start": 217.739,
        "duration": 2.381
    },
    {
        "text": "Normally, you’d test each of those swabs\nindividually, end up with two positive results,",
        "start": 220.12,
        "duration": 4.58
    },
    {
        "text": "and you’re done.",
        "start": 224.7,
        "duration": 1.0
    },
    {
        "text": "But you’ve just used up 60 tests.",
        "start": 225.7,
        "duration": 1.44
    },
    {
        "text": "Another approach would be to pool the swabs\ntogether into, say, 12 groups of five, then",
        "start": 227.14,
        "duration": 4.621
    },
    {
        "text": "test each group.",
        "start": 231.761,
        "duration": 1.179
    },
    {
        "text": "Then you test each individual swab in any\ngroup that comes back positive.",
        "start": 232.94,
        "duration": 3.82
    },
    {
        "text": "Even if the two positive swabs ended up in\ndifferent groups, you’d still be using only",
        "start": 236.76,
        "duration": 3.76
    },
    {
        "text": "22 tests — the first round of 12, and going\nback for ten individual samples.",
        "start": 240.52,
        "duration": 4.41
    },
    {
        "text": "The researchers from Nebraska conducted a\nstudy on this and presented the results to",
        "start": 244.93,
        "duration": 3.8
    },
    {
        "text": "the US Food and Drug Administration, the organization\nresponded that they... wouldn’t object to it.",
        "start": 248.73,
        "duration": 5.37
    },
    {
        "text": "Basically tacit permission for this approach\nto move ahead.",
        "start": 254.1,
        "duration": 2.859
    },
    {
        "text": "Other researchers have proposed ways to get\nreal fancy with the math using computer algorithms,",
        "start": 256.959,
        "duration": 5.33
    },
    {
        "text": "basically optimizing the number of tests that\nare carried out and narrowing down which samples",
        "start": 262.289,
        "duration": 4.1
    },
    {
        "text": "in a pool are positive.",
        "start": 266.389,
        "duration": 1.37
    },
    {
        "text": "Those proposals need to pass peer review,\nbut pooled testing isn’t a new strategy",
        "start": 267.759,
        "duration": 4.03
    },
    {
        "text": "— it’s been in use since at least the\n1940s.",
        "start": 271.789,
        "duration": 2.5
    },
    {
        "text": "If it’s used, this could help us get more\nbang for our buck where testing resources are limited.",
        "start": 274.289,
        "duration": 4.531
    },
    {
        "text": "But these tests still won’t tell us who’s\ncontagious — and that’s something we really",
        "start": 278.82,
        "duration": 4.36
    },
    {
        "text": "need to figure out to make the best decisions\nabout who needs to stay home.",
        "start": 283.18,
        "duration": 3.509
    },
    {
        "text": "Still, we’re learning more and more about\nwhat this disease looks like, even in people",
        "start": 286.689,
        "duration": 3.581
    },
    {
        "text": "who aren’t aware they’re sick.",
        "start": 290.27,
        "duration": 1.769
    },
    {
        "text": "And hopefully, we’ll be able to use that\nknowledge to beat it.",
        "start": 292.039,
        "duration": 3.1
    },
    {
        "text": "Thanks for watching this episode of SciShow.",
        "start": 295.139,
        "duration": 1.5
    },
    {
        "text": "If you want to help us bring more informative\nvideos like this one to the public, consider",
        "start": 296.639,
        "duration": 3.741
    },
    {
        "text": "supporting us on Patreon.",
        "start": 300.38,
        "duration": 1.839
    },
    {
        "text": "Patrons get access to cool perks, like our\ncommunity Discord and exclusive behind the",
        "start": 302.219,
        "duration": 3.57
    },
    {
        "text": "scenes materials, so check it out!",
        "start": 305.789,
        "duration": 1.87
    },
    {
        "text": "To get started, head over to patreon.com/scishow.",
        "start": 307.66,
        "duration": 2.98
    },
    {
        "text": "[ ♪OUTRO ]",
        "start": 310.64,
        "duration": 10.1
    }
]